More on Intuitive Surgical (ISRG): Q1 beats across the board as the company reports a 23% jump...


More on Intuitive Surgical (ISRG): Q1 beats across the board as the company reports a 23% jump in Y/Y revenue despite the headaches surrounding its da Vinci surgical robot. The stock has fallen roughly 15% since February, raising concerns that sales could suffer in FY13. Tune in to the conference call at 4:30 EST here: (Webcast). Shares -0.7% AH.
From other sites
Comments (1)
  • farcry
    , contributor
    Comments (25) | Send Message
     
    ISRG is not about this quarter's or this year's earnings. The key is whether the company can deflect the blame for complications arising from use of the Da Vinci system onto the surgeons performing the operations.
    18 Apr 2013, 05:18 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs